Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Annals of the American Thoracic Society|January 28, 2014
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial diseaseKenneth N Olivier, Pamela A Shaw, Tanya S Glaser, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2023
Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodologyRachel A Mercaldo, Julia E Marshall, Gerard A Cangelosi, et al.
Communications Medicine|July 22, 2023
Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa RicaKaiyuan Sun, Viviana Loria, Amada Aparicio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 21, 2023
Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month PilotCheri Grigg, Kelly A Jackson, Devra Barter, et al.
Plos One|September 3, 2025
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposuresChristopher S Semancik, Romain Fantin, Julia Butt, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Incidence trends of nontuberculous mycobacterial pulmonary infections in Australia, Cambodia, Japan, Thailand, and the United StatesAtha R Pradana, Melinda M Ashcroft, Pichanee Watthanasiri, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Extensively drug-resistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospitalChristie Y Jeon, Soo Hee Hwang, Jin Hong Min, et al.
American Journal of Respiratory and Critical Care Medicine|June 4, 2015
Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic DiseaseEva P Szymanski, Janice M Leung, Cedar J Fowler, et al.
BMC Infectious Diseases|March 19, 2025
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA studyRolando Herrero, Romain Fantin, Viviana Loría, et al.
Pageof 11